-
Novel twists in hormone-mediated carcinogenesis
Wayne D Tilley
Endocrine-Related Cancer
(2016)
23 :E9
-
Bromodomain-containing proteins in prostate cancer
Alfonso Urbanucci and Ian G. Mills
Molecular and Cellular Endocrinology
(2017)
:
-
What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?
Ryan Phillips, Piet Ost, and Phuoc T Tran
Future Oncology
(2017)
13 :2121
-
Epigenetic basis of cancer health disparities: Looking beyond genetic differences
Aamir Ahmad, Shafquat Azim, Haseeb Zubair, Mohammad Aslam Khan, Seema Singh, James E. Carter, Rodney P. Rocconi, and Ajay
P. Singh
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
(2017)
1868 :16
-
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
Daniel Crona and Young Whang
Cancers
(2017)
9 :67
-
AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific
Outcome Under Abiraterone and Enzalutamide
Anna Katharina Seitz, Silvia Thoene, Andreas Bietenbeck, Roman Nawroth, Robert Tauber, Mark Thalgott, Sebastian Schmid, Ramona
Secci, Margitta Retz, Jürgen E. Gschwend, Jürgen Ruland, Christof Winter, and Matthias M. Heck
European Urology
(2017)
72 :828
-
Allosteric alterations in the androgen receptor and activity in prostate cancer
Takuma Uo, Stephen R Plymate, and Cynthia C Sprenger
Endocrine-Related Cancer
(2017)
24 :R335
-
Efficacy of androgen deprivation therapy and the role of oxidative stress
D. K. Price
Annals of Oncology
(2017)
28 :451
-
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant
Prostate Cancer
Daisuke Obinata, Kenichi Takayama, Satoru Takahashi, and Satoshi Inoue
Cancers
(2017)
9 :22
